Shaanxi power semiconductor giant Longteng Semiconductor restarts A-share listing guidance.
Longteng Semiconductor Co., Ltd. applied for counseling and registration on March 30, 2026 at the Shaanxi Securities Regulatory Bureau, planning to conduct an initial public offering and be listed on the stock market, with Guoxin Securities as its counseling institution.
The China Securities Regulatory Commission website disclosed that Longteng Semiconductor Co., Ltd. (referred to as Longteng Semiconductor) completed guidance filing registration with the Shaanxi Securities Regulatory Bureau on March 30, 2026, intending to conduct an initial public offering of stocks and list, with Guosen as its counseling institution. It is understood that this is not Longteng Semiconductor's first attempt to enter the capital market. As early as August 2020, the company signed a guidance agreement with Guosen to prepare for listing on the Science and Technology Innovation Board. In June 2021, the Shanghai Stock Exchange accepted Longteng Semiconductor's application for IPO on the Science and Technology Innovation Board, but three months later the company voluntarily withdrew its listing application, and the exchange subsequently terminated its listing review.
According to public information, Longteng Semiconductor was established in Xi'an, Shaanxi in July 2009 and is a high-tech enterprise dedicated to the research and development, production, sales, and services of new power semiconductor devices. The company has developed seven major product series including high-voltage superjunction MOSFET, insulated gate bipolar transistor (IGBT) and modules, shielded gate trench (SGT) MOSFET, medium and low voltage trench MOSFET, high voltage planar MOSFET, SICJBS & MOSFET, which are widely used in automotive electronics, new energy generation, energy storage, industrial, and consumer electronic fields. They have accumulated over 400 independent intellectual property rights applications, serving more than 1,000 customers, with a workforce of over 600 employees, and have established a strong technical barrier in chip design, production technology, and packaging testing.
The guidance filing report shows that Xu Xichang is the controlling shareholder and actual controller of Longteng Semiconductor. As of now, Xu Xichang controls a total of 35.99% of the company's equity through direct, indirect, and concerted action agreements.
In November 2025, CN INT DEV CORP (00264), a company mainly engaged in leather fashion, announced that they had signed a non-binding memorandum of understanding with Xu Xichang (seller), planning to acquire up to 100% of Longteng Semiconductor's equity for a price ranging from HK$4.5 billion to HK$9 billion. The exclusivity period is three months from the date of the memorandum.
CN INT DEV CORP stated in the announcement that Longteng Semiconductor has a core group with both industry experience and capital vision, effectively expanding its market share in the power semiconductor consumer market. The group believes that the proposed transaction will help further expand its business scope.
In February 2026, CN INT DEV CORP disclosed a supplementary memorandum of understanding and updated progress announcement regarding the proposed transaction, stating that they had signed a supplemental agreement with Xu Xichang to extend the exclusivity period for three months, or a total of six months from the date of the memorandum. CN INT DEV CORP also revealed that they have engaged a professional team, including financial advisors, mainland Chinese lawyers, and Hong Kong lawyers, to conduct due diligence on the target group's business, operations, assets, finances, and legal matters.
Related Articles

Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!
Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


